Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03605901 · ClinicalTrials.gov registry record · Phase 2

Dosing of Methadone for Spine Surgery

A Phase 2 study, sponsored by University of Florida.

Terminated
Registry status
Phase 2
Development phase
21
Enrollment target

NCT03605901 is a Phase 2 study that was terminated before completion, run by University of Florida. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03605901, a Phase 2 study, was terminated before completion, sponsored by University of Florida.

TERMINATED
Registry status
Phase 2
Development phase
21 participants
Enrollment target

Study Summary

This study compares two methods of dosing methadone for complex spine cases

Interventions

  • DRUG Standard dosing of methadone
  • DRUG Aliquots of methadone titrated to apnea

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2019-03-19
Est. Completion 2025-05-09
Phase Phase 2

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT03605901

The ClinicalTrials.gov registry entry for NCT03605901 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard dosing of methadone is the first listed.

NCT03605901 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03605901 about?

NCT03605901 is a clinical study titled "Dosing of Methadone for Spine Surgery". This study compares two methods of dosing methadone for complex spine cases

What is the current status of trial NCT03605901?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2019-03-19. Estimated completion is 2025-05-09.

What interventions are being tested in trial NCT03605901?

The interventions under investigation include: Standard dosing of methadone (DRUG), Aliquots of methadone titrated to apnea (DRUG).

Who is sponsoring clinical trial NCT03605901?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.